Skip to main content

News

Press Release
09/29/2023

 Pulse Biosciences Press Release 

 Pulse Biosciences Press Release...
HAYWARD, CA - September 29, 2023 - Pulse Biosciences, Inc. (Nasdaq: PLSE, “the Company”), a company primarily focused on leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial...
HAYWARD, CA - September 29, 2023 - Pulse Biosciences, Inc. (Nasdaq: PLSE, “the Company”), a company primarily focused on leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial...
HAYWARD, CA - September 29, 2023...
09/29/2023
EP Lab Digest
Press Release
09/26/2023

iRhythm Press Release 

iRhythm Press Release 
iRhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S.
iRhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S.
iRhythm is launching its next...
09/26/2023
EP Lab Digest
Press Release
09/26/2023

Kestra Medical Technologies Press Release 

Kestra Medical Technologies Press Rel...
New ASSURE WCD Enhanced Arrythmia Capabilities Featured
New ASSURE WCD Enhanced Arrythmia Capabilities Featured
New ASSURE WCD Enhanced...
09/26/2023
EP Lab Digest
Press Release
09/26/2023

Viz.ai Press Release 

Viz.ai Press Release 
Expansion brings AI-powered care coordination to underserved communities for clinical trial recruitment
Expansion brings AI-powered care coordination to underserved communities for clinical trial recruitment
Expansion brings AI-powered care...
09/26/2023
EP Lab Digest
Press Release
09/25/2023

Attune Medical Press Release 

Attune Medical Press Release  ...
Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac...
Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac...
Attune Medical has been granted...
09/25/2023
EP Lab Digest
Press Release
09/21/2023

Field Medical Press Release

Field Medical Press Release
Funding supports development and testing of proprietary FieldBending™ catheter ablation platform
Funding supports development and testing of proprietary FieldBending™ catheter ablation platform
Funding supports development and...
09/21/2023
EP Lab Digest
Press Release
09/21/2023

Vektor Medical Press Release

Vektor Medical Press Release
Vektor’s Leadership Team Named HRX AbstracX Innovators, Presenting Groundbreaking Studies on CT Scar Imaging and Wall Thickness Analysis at HRX 2023
Vektor’s Leadership Team Named HRX AbstracX Innovators, Presenting Groundbreaking Studies on CT Scar Imaging and Wall Thickness Analysis at HRX 2023
Vektor’s Leadership Team Named...
09/21/2023
EP Lab Digest
Press Release
09/21/2023

Innovative Health, Inc., Press Release

Innovative Health, Inc., Press Releas...
Advanced medical device reprocessor launches free tool to help hospitals quantify the reduction in carbon emissions possible with a proper EP reprocessing program.
Advanced medical device reprocessor launches free tool to help hospitals quantify the reduction in carbon emissions possible with a proper EP reprocessing program.
Advanced medical device...
09/21/2023
EP Lab Digest
Press Release
09/21/2023

American College of Cardiology, Heart Failure Society of America, Heart Rhythm Society, and Society for Cardiovascular Angiography and Interventions News

American College of Cardiology, Heart...
“It’s time to have a dedicated cardiovascular medicine Board of our own; cardiology is a distinct medical specialty and physicians want—and deserve—a clinical competency and continuous certification program that is meaningful to their...
“It’s time to have a dedicated cardiovascular medicine Board of our own; cardiology is a distinct medical specialty and physicians want—and deserve—a clinical competency and continuous certification program that is meaningful to their...
“It’s time to have a dedicated...
09/21/2023
Cath Lab Digest
Press Release
09/19/2023

Anthos Therapeutics Press Release

Anthos Therapeutics Press Release ...
Abelacimab, a Dual-Acting Factor XI / XIa Inhibitor, Demonstrated an Unprecedented Reduction in Bleeding in the Largest and Longest Head-to-Head Study Comparing a Factor XI Inhibitor to a DOAC
Abelacimab, a Dual-Acting Factor XI / XIa Inhibitor, Demonstrated an Unprecedented Reduction in Bleeding in the Largest and Longest Head-to-Head Study Comparing a Factor XI Inhibitor to a DOAC
Abelacimab, a Dual-Acting Factor...
09/19/2023
EP Lab Digest